Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design, synthesis, and biological evaluation of a potent and selective AURKB degrader.

European journal of medicinal chemistry·2026
Same author

Integrating Conformational Sampling and Siamese Learning to Predict Mutation-Induced Binding Affinity Changes in Abelson Tyrosine Kinase and Its Ligands.

Journal of chemical theory and computation·2026
Same author

Establishing PDK1-based prognostic biomarkers and identifying targeted inhibitors for glioma prognosis and therapy.

BMC neurology·2026
Same author

Advances in Target Identification and Drug Development for Depression.

Current drug targets·2026
Same author

Universal Baseline for <i>in vitro</i> Selection of Genetically Encoded Libraries.

bioRxiv : the preprint server for biology·2026
Same author

Pesticide residues in rice across regions and nations: Contamination profiles, dietary health risks, and mechanism-informed prioritization.

Environment international·2026

Related Experiment Video

Updated: May 16, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.2K

The Applications of Computational Tools in PROTAC Development.

Wangqiu He1, Kejia Yan1, Zhou Chen1

  • 1Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001, China.

Current Topics in Medicinal Chemistry
|April 3, 2025
PubMed
Summary
This summary is machine-generated.

Proteolysis-targeting chimeras (PROTACs) harness E3 ligases for targeted protein degradation. This review details computational tools aiding PROTAC design for diverse therapeutic applications.

Keywords:
PROTACartificial intelligence.molecular dockingmolecular dynamics simulationprotein degradation

More Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.3K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.1K

Related Experiment Videos

Last Updated: May 16, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.2K
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.3K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.1K

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules that induce targeted protein degradation by bridging a protein of interest (POI) with an E3 ubiquitin ligase.
  • PROTACs offer novel therapeutic strategies for diseases like cancer, viral infections, and neurodegenerative disorders due to their unique event-driven pharmacology.
  • The development of PROTACs has garnered significant interest from academic research and the pharmaceutical industry.

Purpose of the Study:

  • To provide a comprehensive overview of computational methodologies employed in the design and development of PROTAC molecules.
  • To elucidate the fundamental principles behind these computational tools and their application in PROTAC discovery.
  • To present experimentally validated examples of computational approaches in PROTAC design.

Main Methods:

  • Review of computational techniques including structural prediction, molecular generation, and molecular dynamics simulations.
  • Analysis of how these methods facilitate the optimization of PROTAC properties, such as binding affinity and degradation efficiency.
  • Integration of computational findings with experimental validation data.

Main Results:

  • Demonstration of the utility of computational tools in accelerating PROTAC development.
  • Highlighting the successful application of various computational strategies in designing effective PROTACs.
  • Identification of key computational approaches that have led to experimentally validated PROTAC candidates.

Conclusions:

  • Computational methods are indispensable for efficient PROTAC design and optimization.
  • The integration of computational tools with experimental validation is crucial for advancing PROTAC-based therapeutics.
  • PROTACs represent a promising therapeutic modality with broad applicability, significantly aided by in silico approaches.